Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2020-06-05 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CStone Pharmaceuticals, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to employee share option exercises and share repurchases, with dates, quantities, prices, and confirmations of compliance with listing rules. The document is regulatory in nature, reporting capital changes and share repurchase activities, not a full financial report or earnings release. It fits the category of announcements regarding share capital changes and share buybacks. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2020-06-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/05/2020. It is addressed to the Hong Kong Exchanges and Clearing Limited, indicating it is a regulatory filing related to share capital changes. The content is focused on share capital movements and confirmations related to securities issuance, not a financial report, earnings release, or management discussion. It is a detailed regulatory disclosure about share capital changes rather than a report or announcement of a report. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (15,000 characters) and detailed tables support it being a substantive filing rather than a brief announcement or certification.
2020-06-04 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including share options, warrants, convertibles, and other share issuances or repurchases for the month ended 31/05/2020. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory disclosure about share capital changes rather than a financial report or announcement of voting results. Given the detailed nature of share capital movements and the monthly frequency, this fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains actual data on share capital changes, not just an announcement or certification, so it is not RPA or RNS.
2020-06-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CStone Pharmaceuticals, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to employee share options and share repurchases, with dates, quantities, prices, and confirmations of compliance with listing rules. The document is regulatory in nature, reporting capital changes and share repurchase activities as required by the Hong Kong Stock Exchange Listing Rules. It is not a full financial report, earnings release, or management discussion, but a formal disclosure of capital changes and share buybacks. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is not a mere announcement but a formal disclosure report.
2020-05-29 English
VOLUNTARY ANNOUNCEMENT-SHARE REPURCHASE
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by Yanzhou Coal Mining Company Limited regarding updates on the company's share repurchase activities. It references the Repurchase Mandate approved at previous meetings and provides specific details about the number of shares repurchased, the percentage of issued share capital, and the aggregate consideration. The document is relatively short (2475 characters) and focuses solely on the share repurchase update without containing comprehensive financial statements or broader financial performance data. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares.
2020-05-29 English
Notification Letter
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Yanzhou Coal Mining Company Limited dated 29 May 2020. It informs shareholders about the publication of the circular for the 2019 Annual General Meeting (AGM) and Class Meeting of the Holders of H Shares. The letter provides instructions on how shareholders can access the circular online or request printed copies, and includes a change request form for shareholders to update their preferences for receiving corporate communications. The document does not contain the actual circular or detailed financial data but rather announces the availability of the circular and related corporate communications. It fits the definition of a Report Publication Announcement (RPA), which is an announcement regarding the timing, release, or publication of company reports or communications, often stating the report is attached or available on the website. The document length (9263 characters) and content support this classification as it is primarily a notification and request form rather than the report itself.
2020-05-29 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.